CHAPTER 212
HB 1681-FN - FINAL VERSION
9Mar2016... 0634h
05/05/2016 1487s
05/05/2016 1880s
2016 SESSION
\t16-2501
\t01/10
HOUSE BILL\t1681-FN
AN ACT\testablishing a commission on hypodermic syringes and needles.
SPONSORS:\tRep. Hannon, Straf. 25; Rep. Bouldin, Hills. 12; Rep. Edwards, Hills. 11; Rep. Frazer, Merr. 13; Rep. Wright, Carr. 8; Rep. J. Ward, Rock. 19; Rep. Avellani, Carr. 5; Rep. Biggie, Hills. 23; Rep. Hull, Graf. 9; Rep. C. McGuire, Merr. 29; Sen. Boutin, Dist 16; Sen. Watters, Dist 4
COMMITTEE:\tHealth, Human Services and Elderly Affairs
-----------------------------------------------------------------
AMENDED ANALYSIS
\tThis bill establishes a commission on hypodermic syringes and needles.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation:\tMatter added to current law appears in bold italics.
\t\tMatter removed from current law appears [in brackets and struckthrough.]
\t\tMatter which is either (a) all new or (b) repealed and reenacted appears in regular type.
9Mar2016... 0634h\t16-2501
05/05/2016 1487s\t01/10
05/05/2016 1880s
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Sixteen
AN ACT\testablishing a commission on hypodermic syringes and needles.
Be it Enacted by the Senate and House of Representatives in General Court convened:
\t212:1 New Section; Commission on Hypodermic Syringes and Needles. Amend RSA 318-B by inserting after section 26-a the following new section:
\t318-B:26-b Commission on Hypodermic Syringes and Needles.
\t\tI. There is established a commission on hypodermic syringes and needles.
\t\tII. The members of the commission shall be as follows:
\t\t\t(a) Two members of the house of representatives, appointed by the speaker of the house of representatives.
\t\t\t(b) One member of the senate, appointed by the president of the senate.
\t\t\t(c) The commissioner of the department of health and human services, or designee.
\t\t\t(d) The commissioner of the department of environmental services, or designee.
\t\t\t(e) The attorney general, or designee.
\t\t\t(f) A pharmacist, appointed by the New Hampshire board of pharmacy.
\t\t\t(g) A physician from the New Hampshire Medical Society, appointed by the society.
\t\t\t(h) A representative from the New Hampshire Infection Control and Epidemiology Professionals, appointed by that organization.
\t\t\t(i) Two public members, at least one of whom shall be an independent office-based health care practitioner, appointed by the governor.
\t\t\t(j) An APRN, appointed by the New Hampshire Nurse Practitioner Association.
\t\t\t(k) The chair of the governor's commission on alcohol and drug abuse prevention, treatment, and recovery, or designee.
\t\t\t(l) The director of the division of state police, or designee.
\t\t\t(m) The governor's advisor on addiction and behavioral health, or designee.
\t\t\t(n) The president of the New Hampshire Association of Chiefs of Police, or designee.
\t\t\t(o) The executive director of New Futures, or designee.
\t\t\t(p) A member of the public health network, appointed by the commissioner of the department of health and human services.
\t\t\t(q) A representative from an HIV/AIDS service organization, appointed by the governor.
\t\t\t(r) An individual who is in long-term recovery, appointed by the commissioner of the department of health and human services.
\t\tIII. Legislative members of the commission shall receive mileage at the legislative rate when attending to the duties of the commission.
\t\tIV.(a) The commission's study shall include, but not be limited to:
\t\t\t\t(1) Studying the national standards for best practices for syringe services programs.
\t\t\t\t(2) Discussing the feasibility of implementing syringe services programs in New Hampshire.
\t\t\t\t(3) Identifying recommended solutions, both legislative and non-legislative.
\t\t\t\t(4) Reviewing any other matter the commission deems relevant to its objective.
\t\t\t(b) The commission shall seek input from any person or entity the commission deems relevant to its study.
\t\tV. The members of the commission shall elect a chairperson from among the members. The first meeting of the commission shall be called by the first-named member of the house of representatives. The first meeting of the commission shall be held within 30 days of the effective date of this section. Eleven members of the commission shall constitute a quorum.
\t\tVI. The commission shall report its findings and any recommendations for proposed legislation to the speaker of the house of representatives, the president of the senate, the house clerk, the senate clerk, the governor, and the state library on or before November 1, 2016.
\t212:2 Repeal. RSA 318-B:26-b, relative to the commission on hypodermic syringes and needles, is repealed.
\t\tI. Section 2 of this act shall take effect November 1, 2016.
\t\tII. The remainder of this act shall take effect upon its passage.
Approved: June 6, 2016
Effective Date:\t\tI. Section 2 shall take effect Novemer 1, 2016
\t\t\t\t II. Remainder shall take effect June 6, 2016